Summary:
- Hope Medicine, Inc. announced positive results from a global Phase 2 study of their first-in-class endometriosis treatment.
- The treatment demonstrated significant improvements in pain reduction and quality of life for women with endometriosis, a chronic and debilitating condition affecting millions of women worldwide.
- The treatment has been granted Breakthrough Therapy Designation by the FDA, which is intended to expedite the development and review of drugs that treat serious or life-threatening conditions.